Intrinsiqq
908 Devices Inc. logo

908 Devices Inc. (MASS) Insider Trading

Last 12 months

Insiders sold $5.78M and bought nothing on the open market.

90% of the selling was scheduled in advance under 10b5-1 plans. SVP, Sales & Product Marketing John Kenneweg sold $148k on May 8, 24% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market
−$5.78M
0 buys · 28 sales
Under a 10b5-1 plan
90%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
May 2025
May 15, 2025

Get an email when MASS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 710b5-1 plan
    Christopher D. Brown
    Director · sold 30,000 at $11.89
    $357k
    3.6% of stake
  • Oct 610b5-1 plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 5,000 at $13.03
    $65k
    4.1% of stake
  • Sep 29No plan
    AWM Investment Company, Inc.
    Large holder · sold 18,000 at $11.52
    $207k
    0.4% of stake
  • Sep 23 – 24No plan
    AWM Investment Company, Inc.
    Large holder · sold 25,000 at avg $11.36
    $284k
    0.3% of stake
  • Sep 15 – 1710b5-1 plan
    John Kenneweg
    SVP, Sales & Product Marketing · sold 27,656 at avg $10.13
    $280k
    32% of stake
  • Sep 210b5-1 plan
    Christopher D. Brown
    Director · sold 30,000 at $10.58
    $317k
    3.7% of stake
  • Aug 2510b5-1 plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 11,459 at $10.95
    $125k
    8.6% of stake
  • Aug 20 – 21No plan
    AWM Investment Company, Inc.
    Large holder · sold 50,000 at avg $10.59
    $530k
    1.0% of stake
  • Aug 13 – 1710b5-1 plan
    Kevin J. Knopp
    President and CEO · sold 27,622 at avg $10.27
    $284k
    2.5% of stake
  • Aug 10 – 1210b5-1 plan
    Kevin J. Knopp
    President and CEO · sold 149,013 at avg $9.90
    $1.48M
    12% of stake
  • Aug 10 – 1110b5-1 plan
    Christopher D. Brown
    Director · sold 17,800 at avg $9.12
    $162k
    2.2% of stake
  • Aug 510b5-1 plan
    Christopher D. Brown
    Director · sold 20,000 at $8.49
    $170k
    2.4% of stake
  • Aug 4No plan
    AWM Investment Company, Inc.
    Large holder · sold 50,000 at $8.36
    $418k
    1.0% of stake
  • Jul 210b5-1 plan
    Christopher D. Brown
    Director · sold 2,200 at $9.02
    $20k
    0.3% of stake
  • Jul 210b5-1 plan
    Kevin J. Knopp
    President and CEO · sold 222 at $9.07
    $2k
    <0.1% of stake
  • Jun 3010b5-1 plan
    Christopher D. Brown
    Director · sold 20,000 at $8.84
    $177k
    2.3% of stake
  • Jun 2610b5-1 plan
    Kevin J. Knopp
    President and CEO · sold 2,798 at $9.09
    $25k
    0.2% of stake
  • Jun 23 – 2510b5-1 plan
    Kevin J. Knopp
    President and CEO · sold 60,345 at avg $9.12
    $551k
    4.5% of stake
  • Jun 2310b5-1 plan
    Christopher D. Brown
    Director · sold 9,900 at $9.04
    $89k
    1.1% of stake
  • Jun 22 – 23No plan
    AWM Investment Company, Inc.
    Large holder · sold 7,718 at avg $8.99
    $69k
    0.2% of stake
  • Jun 410b5-1 plan
    Christopher D. Brown
    Director · sold 100 at $9.00
    $900
    <0.1% of stake
  • Jun 2 – 4No plan
    AWM Investment Company, Inc.
    Large holder · sold 42,282 at avg $8.97
    $379k
    0.9% of stake
  • Jun 310b5-1 plan
    Christopher D. Brown
    Director · sold 20,000 at $8.73
    $175k
    2.2% of stake
  • May 2810b5-1 plan
    Christopher D. Brown
    Director · sold 30,000 at $9.00
    $270k
    3.2% of stake
  • May 27 – 28No plan
    AWM Investment Company, Inc.
    Large holder · sold 186,942 at avg $8.62
    $1.61M
    3.7% of stake
  • May 2810b5-1 plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 6,940 at $9.03
    $63k
    5.0% of stake
  • May 11No plan
    AWM Investment Company, Inc.
    Large holder · sold 5,000 at $8.25
    $41k
    <0.1% of stake
  • May 8No plan
    John Kenneweg
    SVP, Sales & Product Marketing · sold 18,255 at $8.11
    $148k
    24% of stake
  • May 6 – 8No plan
    AWM Investment Company, Inc.
    Large holder · sold 78,209 at avg $8.08
    $632k
    1.5% of stake
  • May 610b5-1 plan
    Christopher D. Brown
    Director · sold 20,000 at $7.23
    $145k
    2.1% of stake
  • May 1No plan
    John Kenneweg
    SVP, Sales & Product Marketing · sold 7,787 at $6.83
    $53k
    9.3% of stake
  • Apr 1010b5-1 plan
    Kevin J. McCallion
    SVP, Products and Production · sold 2,693 at $7.01
    $19k
    5.7% of stake
  • Apr 8 – 1010b5-1 plan
    Christopher D. Brown
    Director · sold 40,000 at avg $7.06
    $282k
    4.1% of stake
  • Apr 8 – 910b5-1 plan
    Kevin J. McCallion
    SVP, Products and Production · sold 24,000 at avg $7.05
    $169k
    35% of stake
  • Mar 210b5-1 plan
    Kevin J. McCallion
    SVP, Products and Production · sold 7 at $7.00
    $49
    <0.1% of stake
  • Feb 2No plan
    Kevin J. Knopp
    President and CEO · sold 34,764 at $6.18
    $215k
    2.5% of stake
  • Feb 2No plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 23,175 at $6.18
    $143k
    14% of stake
  • Oct 2, 2025 – Oct 3, 202510b5-1 plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 5,000 at avg $9.05
    $45k
    5.1% of stake
  • Sep 19, 202510b5-1 plan
    Joseph H. Griffith IV
    Chief Financial Officer · sold 5,000 at $7.07
    $35k
    4.9% of stake
  • Jun 16, 2025 – Jun 18, 202510b5-1 plan
    Michael S. Turner
    Chief Legal & Admin Officer · sold 24,603 at avg $7.51
    $185k
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MASS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Laboratory Analytical Instruments

Spot a number that looks wrong? Check it in MASS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MASS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.